An important link between obesity, the metabolic syndrome, and dyslipidemia, seems to be the development of insulin resistance in peripheral tissues leading to an enhanced hepatic flux of fatty acids from dietary sources, intravascular lipolysis, and from adipose tissue resistant to the antilipolytic effects of insulin [32]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.